KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Eli Lilly (LLY) over the last 14 years, with Q3 2025 value amounting to $897.8 million.

  • Eli Lilly's Shares Outstanding (Weighted Average) fell 35.52% to $897.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $897.8 million, marking a year-over-year decrease of 35.52%. This contributed to the annual value of $900.6 million for FY2024, which is 4.71% up from last year.
  • Latest data reveals that Eli Lilly reported Shares Outstanding (Weighted Average) of $897.8 million as of Q3 2025, which was down 35.52% from $898.3 million recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Shares Outstanding (Weighted Average) registered a high of $908.8 million during Q1 2021, and its lowest value of $897.8 million during Q3 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $901.0 million (2023), whereas its average is $902.1 million.
  • As far as peak fluctuations go, Eli Lilly's Shares Outstanding (Weighted Average) crashed by 68.27% in 2022, and later increased by 8.89% in 2024.
  • Over the past 5 years, Eli Lilly's Shares Outstanding (Weighted Average) (Quarter) stood at $907.0 million in 2021, then decreased by 0.58% to $901.7 million in 2022, then fell by 0.17% to $900.2 million in 2023, then increased by 0.05% to $900.6 million in 2024, then decreased by 0.31% to $897.8 million in 2025.
  • Its last three reported values are $897.8 million in Q3 2025, $898.3 million for Q2 2025, and $898.7 million during Q1 2025.